1H- and 31P-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes

[1]  M. E. Kooi,et al.  MRS: a noninvasive window into cardiac metabolism , 2015, NMR in biomedicine.

[2]  K. Shimada,et al.  Evaluation of myocardial triglyceride accumulation assessed on 1H-magnetic resonance spectroscopy in apparently healthy Japanese subjects. , 2015, Internal medicine.

[3]  H. Lamb,et al.  Exercise and type 2 diabetes mellitus: changes in tissue-specific fat distribution and cardiac function. , 2013, Radiology.

[4]  A. Garg,et al.  Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging. , 2013, The American journal of cardiology.

[5]  B. Maron,et al.  Hypertrophic cardiomyopathy , 2013, The Lancet.

[6]  S. Neubauer,et al.  1H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism , 2012, Heart Failure Reviews.

[7]  F. Carré.  [Athlete's heart or hypertrophic cardiomyopathy?]. , 2012, Presse medicale.

[8]  S. Neubauer,et al.  Clinical cardiac magnetic resonance spectroscopy. , 2011, Progress in cardiovascular diseases.

[9]  J. Schulz-Menger,et al.  Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin-resistant obese women , 2011, Heart.

[10]  H. Lamb,et al.  Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction , 2011 .

[11]  F. Sardanelli,et al.  Relation of echocardiographic epicardial fat thickness and myocardial fat. , 2010, The American journal of cardiology.

[12]  F. Podo,et al.  In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. , 2009, AJR. American journal of roentgenology.

[13]  A. Del Maschio,et al.  Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. , 2009, AJR. American journal of roentgenology.

[14]  J. Ingwall.  Energy metabolism in heart failure and remodelling. , 2008, Cardiovascular research.

[15]  Francesco Sardanelli,et al.  Biostatistics for Radiologists: Planning, Performing, and Writing a Radiologic Study , 2008 .

[16]  P. Scifo,et al.  Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging , 2008, Heart.

[17]  M. Link,et al.  Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2008 .

[18]  Jeroen J. Bax,et al.  Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. , 2007, Radiology.

[19]  D. Graveron-Demilly,et al.  Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[20]  F. Sardanelli,et al.  MR spectroscopy of the heart , 2006, La radiologia medica.

[21]  A. Tajik,et al.  Sarcomeric genotyping in hypertrophic cardiomyopathy. , 2005, Mayo Clinic proceedings.

[22]  W. Kaiser,et al.  Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging , 2005, European Radiology.

[23]  A. Blamire,et al.  Abnormal cardiac energetics in patients carrying the A3243G mtDNA mutation measured in vivo using phosphorus MR spectroscopy. , 2004, Biochimica et biophysica acta.

[24]  P. Elliott,et al.  Hypertrophic cardiomyopathy , 2004, The Lancet.

[25]  H. Amthauer,et al.  Comparison of Different Cardiac MRI Sequences at 1.5 T/3.0 T with Respect to Signal-to-Noise and Contrast-to-Noise Ratios - Initial Experience* , 2004, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[26]  S. Morikawa,et al.  Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[27]  W. Mckenna,et al.  Risk of competitive sport in young athletes with heart disease , 2003, Heart.

[28]  A. Blamire,et al.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. , 2003, Journal of the American College of Cardiology.

[29]  Wigle Ed,et al.  The diagnosis of hypertrophic cardiomyopathy , 2001, Heart.

[30]  P A Bottomley,et al.  Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium. , 2001, Radiology.

[31]  B Jung,et al.  Methods and reproducibility of cardiac/respiratory double‐triggered 1H‐MR spectroscopy of the human heart , 1999, Magnetic resonance in medicine.

[32]  O. Lutz,et al.  31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. , 1998, Circulation.

[33]  P. Bottomley,et al.  Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium , 1998, The Lancet.

[34]  A. Zwinderman,et al.  Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. , 1998, Circulation.

[35]  O. Lutz,et al.  P NMR Spectroscopy Detects Metabolic Abnormalities in Asymptomatic Patients With Hypertrophic Cardiomyopathy , 1998 .

[36]  M. Komajda,et al.  Penetrance of familial hypertrophic cardiomyopathy. , 1997, Genetic counseling.

[37]  H. Vliegen,et al.  Phosphorus magnetic resonance spectroscopy of the human heart: current status and clinical implications. , 1996, European heart journal.

[38]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[39]  D. Salem,et al.  Sudden cardiac death and the 'athlete's heart'. , 1995, Archives of internal medicine.

[40]  B. Maron,et al.  Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. , 1995, Circulation.

[41]  G M Pohost,et al.  Observation of cardiac lipids in humans by localized 1H magnetic resonance spectroscopic imaging , 1994, Magnetic resonance in medicine.

[42]  M. Proschan,et al.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. , 1991, The New England journal of medicine.